Clinical Outcome of Eradication Therapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma according to H. pylori Infection Status
Table 2
Clinical response to eradication therapy according to H. pylori infection status.
Variables
H. pylori+ ()
H. pylori− ()
value
Initial H. pylori eradication (%)
41 (100)
6 (50)
Successful eradication (%)
35 (85)
Response to H. pylori eradication (%)
Complete remission
35 (85)
3 (50)
0.133
Partial remission
2 (5)
0 (0)
Stable disease
4 (10)
2 (33)
Progressive disease
0 (0)
1 (17)
Median time to achieve CR (month, SD)
4.8 (1.1)
6.1 (1.5)
0.108
CR maintenance period (month, SD)
28.0 (19.1)
32.0 (18.0)
0.442
Relapse rate after CR
3 (9)
1 (33)
0.718
One patient received chemotherapy initially due to advanced stage. Three patients underwent chemotherapy and other three patients were treated with radiotherapy initially. SD: standard deviation; H. pylori: Helicobacter pylori; CR: complete remission.
